Upregulation of Mitf by Phenolic Compounds-Rich Cymbopogon schoenanthus Treatment Promotes Melanogenesis in B16 Melanoma Cells and Human Epidermal Melanocytes

Melanin provides inherent protection against skin cancer by absorbing broad-spectrum radiant energy of UV radiation. Cutaneous malignant melanoma incidence has recently been observed to increase and the frequency is closely associated with the skin color, highlighting the importance of skin pigmentation. Here, we showed how melanin biosynthesis is enhanced by treatment with phenolic compounds-rich Cymbopogon schoenanthus (CYM) in B16 murine melanoma cells and human epidermal melanocytes (HEM). CYM increased the melanin content of the cells by upregulating the expression of tyrosinase (TYR), tyrosinase-related protein 1 (TRP1), and dopachrome tautomerase (DCT) at the protein and mRNA levels, comparable to the effect of α-melanocyte-stimulating hormone (MSH), in both B16 cells and HEM. Moreover, global gene expression analysis showed that at least 44 pigmentation-associated genes were modulated, including the microphthalmia-associated transcription factor (Mitf) and its transcriptional regulators (Sox10, Pax3, and Lef1). Upregulation of copper transport-associated gene Atp7b indicates that CYM also promotes tyrosinase activity. CYM upregulated Mitf and possibly activates tyrosinase enzyme, providing evidence for its possible use to promote melanogenesis and as a therapeutic agent against hypopigmentation disorders.

[1]  R. Anderson.  Optics of the Skin , 2018, Clinical Photomedicine.

[2]  C. A. Ramsden,et al.  Tyrosinase: the four oxidation states of the active site and their relevance to enzymatic activation, oxidation and inactivation. , 2014, Bioorganic & medicinal chemistry.

[3]  H. Isoda,et al.  Antistress Effects of the Ethanolic Extract from Cymbopogon schoenanthus Growing Wild in Tunisia , 2013, Evidence-based complementary and alternative medicine : eCAM.

[4]  T. Mitsunaga,et al.  Melanogenesis acceleratory activity of synthesized quercetin derivatives and the structure activity relationships , 2013 .

[5]  H. Isoda,et al.  Lupenone from Erica multiflora Leaf Extract Stimulates Melanogenesis in B16 Murine Melanoma Cells through the Inhibition of ERK1/2 Activation , 2013, Planta Medica.

[6]  H. Swalwell,et al.  Investigating the role of melanin in UVA/UVB- and hydrogen peroxide-induced cellular and mitochondrial ROS production and mitochondrial DNA damage in human melanoma cells. , 2012, Free radical biology & medicine.

[7]  M. Picardo,et al.  Wnt/β‐catenin signaling is stimulated by α‐melanocyte‐stimulating hormone in melanoma and melanocyte cells: implication in cell differentiation , 2011, Pigment cell & melanoma research.

[8]  V. Hearing,et al.  Update on the regulation of mammalian melanocyte function and skin pigmentation. , 2011, Expert review of dermatology.

[9]  A. Lino,et al.  Antioxidant, antiacetylcholinesterase and antimicrobial activities of Cymbopogon schoenanthus L. Spreng (lemon grass) from Tunisia , 2010 .

[10]  I. Raskin,et al.  A natural history of botanical therapeutics. , 2008, Metabolism: clinical and experimental.

[11]  K. Kang,et al.  The anti-melanogenic effect of pycnogenol by its anti-oxidative actions. , 2008, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[12]  V. Hearing,et al.  The Protective Role of Melanin Against UV Damage in Human Skin † , 2008, Photochemistry and photobiology.

[13]  Ilya Raskin,et al.  Revisiting the ancient concept of botanical therapeutics. , 2007, Nature chemical biology.

[14]  D. Fisher,et al.  Melanocyte biology and skin pigmentation , 2007, Nature.

[15]  Hugh M Gloster,et al.  Skin cancer in skin of color. , 2006, Journal of the American Academy of Dermatology.

[16]  D. Fisher,et al.  Topical drug rescue strategy and skin protection based on the role of Mc1r in UV-induced tanning , 2006, Nature.

[17]  D. Fisher,et al.  MITF: master regulator of melanocyte development and melanoma oncogene. , 2006, Trends in molecular medicine.

[18]  A. Gurib-Fakim,et al.  Medicinal plants: traditions of yesterday and drugs of tomorrow. , 2006, Molecular aspects of medicine.

[19]  Tim K. Lee,et al.  Tanning Beds, Sunlamps, and Risk of Cutaneous Malignant Melanoma , 2005, Cancer Epidemiology Biomarkers & Prevention.

[20]  D. Tobin,et al.  Melanin pigmentation in mammalian skin and its hormonal regulation. , 2004, Physiological reviews.

[21]  P. Elsner,et al.  Oxidative stress in malignant melanoma and non‐melanoma skin cancer , 2003, The British journal of dermatology.

[22]  Karen Emmons,et al.  Use of sunscreen, sunburning rates, and tanning bed use among more than 10 000 US children and adolescents. , 2002, Pediatrics.

[23]  F. Solano,et al.  Inhibition of melanogenesis in response to oxidative stress: transient downregulation of melanocyte differentiation markers and possible involvement of microphthalmia transcription factor. , 2001, Journal of cell science.

[24]  J. Mercer,et al.  The molecular basis of copper-transport diseases. , 2001, Trends in molecular medicine.

[25]  N. Holbrook,et al.  Oxidants, oxidative stress and the biology of ageing , 2000, Nature.

[26]  C. Goding,et al.  Mitf from neural crest to melanoma: signal transduction and transcription in the melanocyte lineage. , 2000, Genes & development.

[27]  T. Ohnishi,et al.  Supranuclear melanin caps reduce ultraviolet induced DNA photoproducts in human epidermis. , 1998, The Journal of investigative dermatology.

[28]  A. Brunet,et al.  Inhibition of the Mitogen-activated Protein Kinase Pathway Triggers B16 Melanoma Cell Differentiation* , 1998, The Journal of Biological Chemistry.

[29]  C. Kamei,et al.  Effects of certain resorcinol derivatives on the tyrosinase activity and the growth of melanoma cells. , 1998, Methods and findings in experimental and clinical pharmacology.

[30]  P. Riley.  Molecules in focusMelanin , 1997 .

[31]  I. Jackson,et al.  Structure of the mouse tyrosinase-related protein-2/dopachrome tautomerase (Tyrp2/Dct) gene and sequence of two novel slaty alleles. , 1995, Genomics.

[32]  S. Kuge,et al.  The expression of tyrosinase, tyrosinase-related proteins 1 and 2 (TRP1 and TRP2), the silver protein, and a melanogenic inhibitor in human melanoma cells of differing melanogenic activities. , 1995, Pigment cell research.

[33]  A. Monaghan,et al.  A cell‐specific enhancer far upstream of the mouse tyrosinase gene confers high level and copy number‐related expression in transgenic mice. , 1994, The EMBO journal.

[34]  Robert M. Sayre,et al.  New trends in photobiology: Photoprotection by melanin , 1991 .

[35]  J. Pawelek,et al.  Mammalian tyrosinase catalyzes three reactions in the biosynthesis of melanin. , 1982, Science.

[36]  D L DEY,et al.  SKIN CANCERS , 1957, The Medical journal of Australia.

[37]  F. Figge.  Melanin , 1939, The New England journal of medicine.

[38]  K. Kilgore,et al.  Development of an in vitro primary screen for skin depigmentation and antimelanoma agents. , 1994, Skin pharmacology : the official journal of the Skin Pharmacology Society.

[39]  A. Eison,et al.  Melatonin binding sites are functionally coupled to phosphoinositide hydrolysis in Syrian hamster RPMI 1846 melanoma cells. , 1993, Life sciences.